Related Funds
Fund Name | Location |
Acquipharma | - |
Canadian Government | Canada, Ontario, Ottawa |
China Trends Holdings | China, Hong Kong, Hong Kong Island |
Dahua Technology | Binjiang, China, Jiangxi |
Era Funding Administration | - |
Ericsson Ventures | California, Santa Clara, United States |
Glaxo Group | Brentford, Hounslow, United Kingdom |
NDFOS | Seoul, Seoul-t'ukpyolsi, South Korea |
Octava | Georgia, Norcross, United States |
PolyTechnos Venture Partners | Bayern, Germany, Munich |
RATNAAFIN | Ahmedabad, Gujarat, India |
S.A.C. Capital Advisors | Connecticut, Stamford, United States |
Silence Therapeutics | England, London, United Kingdom |
Technology Venture Partners | Bristol, England, United Kingdom |
Trevi Health Ventures | New York, New York, United States |
Xinjiang Guanghui Chelianwang Touzi Guanli Youxian Gongsi | China, Ürümqi, Xinjiang |
Yamaguchi Bank | Japan, Shimonoseki, Yamaguchi Prefecture |
Yaotian Keji | Beijing, China, Pinggu |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Fizimed | $708K | 23 Mar 2018 | Grand Est | ||
Serious Factory | $3M | 13 Mar 2018 | Ile-de-France | ||
Medicapp Connect | $531K | 01 Jun 2015 | Sèvres, Ile-de-France, France | ||
$350K | 01 Jan 2014 | Paris, Ile-de-France, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Fizimed | $708K | 23 Mar 2018 | Grand Est | ||
Serious Factory | $3M | 13 Mar 2018 | Ile-de-France | ||
Medicapp Connect | $531K | 01 Jun 2015 | Sèvres, Ile-de-France, France | ||
$350K | 01 Jan 2014 | Paris, Ile-de-France, France |